Verteporfin photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia: A 12-month retrospective review

European Journal of Ophthalmology

Volumn 18, Issue 6, 2008, Pages 955-959

  Costagliola, Ciro ^a   Campa, C ^b   Incorvaia, C ^b   Parmeggiani, F ^b   Menzione, M ^c   Della Corte, M ^c   Rinaldi, M ^c   Romano, M ^c   Semeraro, F ^d  

^a UNIVERSITY OF MOLISE   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Choroidal neovascularization; Myopia; Photodynamic therapy

Indexed keywords

VERTEPORFIN; PHOTOSENSITIZING AGENT; PORPHYRIN;

ADULT; AGED; ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOPIA; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISUAL ACUITY; DEGENERATIVE MYOPIA; MIDDLE AGED; PATHOPHYSIOLOGY; PHOTOCHEMOTHERAPY; PHYSIOLOGY; RETINA FOVEA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; HUMANS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 58149374857     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210801800616     Document Type: Article

References (17)

1. Curtin BJ, Karlin DB. Axial length measurements and fundus changes in the myopic eye. Am J Ophthalmol 1971; 71: 42-50.
2. Grossniklaus HE, Green WR. Pathologic findings in pathologic myopia. Retina 1992; 12: 127-33.
3. Spitznas M, Böker T. Idiopathic posterior subretinal neovascularization (IPSN) is related to myopia. Graefes Arch Clin Exp Ophthalmol 1991; 229: 536-8.
4. Jalkh AE, Weiter JJ, Trempe CL, Pruett RC, Schepens CL. Choroidal neovascularization in degenerative myopia: role of laser photocoagulation. Ophthalmic Surg 1987; 18: 721-5.
5. Ruiz-Moreno JM, de La Vega C. Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients. Br J Ophthalmol 2001; 85: 1041-3.
6. VIP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001; 108: 841-52.
7. VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - verteporfin in photodynamic therapy. Report 2. Am J Ophthalmol 2001; 131: 541-60.
8. Tewari A, Dhalla MS, Apte RS. Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia. Retina 2006; 26: 1093-4.
9. Sakaguchi H, Ikuno Y, Gomi F, et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol 2007; 91: 161-5.
10. Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. Br J Ophthalmol 2007; 91: 57-60.
11. Pece A, Isola V, Vadala M, Matranga D. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study. Retina 2006; 26: 746-51.
12. Axer-Siegel R, Ehrlich R, Weinberger D, et al. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment. Am J Ophthalmol 2004; 138: 602-7.
13. Montero JA, Ruiz-Moreno JM. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation. Br J Ophthalmol 2003; 87: 173-6.
14. Lam DS, Chan WM, Liu DT, Fan DS, Lai WW, Chong KK. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up. Br J Ophthalmol 2004; 88: 1315-9.
15. Hayashi K, Ohno-Matsui K, Teramukai S, et al. Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls. Am J Ophthalmol 2008; 145: 518-26.
16. Yang N, Fan CM, Ho CK. Review of first year result of photodynamic therapy on age-related macular degeneration in Chinese population. Eye 2006; 20: 523-6.
17. Ergun E, Heinzl H, Stur M. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol 2004; 138: 434-8.